Works by Meneghini, Luigi


Results: 73
    1
    2
    3
    4

    Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta‐analysis.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2137, doi. 10.1111/dom.14455
    By:
    • Powell, Rhea E.;
    • Zaccardi, Francesco;
    • Beebe, Christine;
    • Chen, Xin Mei;
    • Crawford, Alyssa;
    • Cuddeback, John;
    • Gabbay, Robert A.;
    • Kissela, Lauren;
    • Litchman, Michelle L.;
    • Mehta, Rajesh;
    • Meneghini, Luigi;
    • Pantalone, Kevin M.;
    • Rajpathak, Swapnil;
    • Scribner, Paul;
    • Skelley, Jessica W.;
    • Khunti, Kamlesh
    Publication type:
    Article
    5

    Cover Image, Volume 22, Issue 11.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1, doi. 10.1111/dom.14229
    By:
    • Meneghini, Luigi F.;
    • Sullivan, Sean D.;
    • Oster, Gerry;
    • Busch, Robert;
    • Cali, Anna M. G.;
    • Dauchy, Arnaud;
    • Gill, Jasvinder;
    • Bailey, Timothy S.
    Publication type:
    Article
    6
    7
    8

    A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal‐bolus insulin or a glucagon‐like peptide‐1 receptor agonist plus basal‐bolus insulin: The SIMPLE study

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2133, doi. 10.1111/dom.13794
    By:
    • Abreu, Marconi;
    • Tumyan, Anna;
    • Elhassan, Ahmed;
    • Peicher, Katherine;
    • Papacostea, Olivia;
    • Dimachkie, Perihan;
    • Siddiqui, Muhammad S.;
    • Pop, Laurentiu M.;
    • Gunasekaran, Uma;
    • Meneghini, Luigi F.;
    • Adams‐Huet, Beverley;
    • Li, Xilong;
    • Lingvay, Ildiko
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes.

    Published in:
    2013
    By:
    • Meneghini, Luigi;
    • Atkin, Stephen L;
    • Gough, Stephen C L;
    • Raz, Itamar;
    • Blonde, Lawrence;
    • Shestakova, Marina;
    • Bain, Stephen;
    • Johansen, Thue;
    • Begtrup, Kamilla;
    • Birkeland, Kåre I;
    • NN1250-3668 (BEGIN FLEX) Trial Investigators
    Publication type:
    journal article
    28
    29

    Insulin Degludec in Type 1 Diabetes.

    Published in:
    Diabetes Care, 2011, v. 34, n. 3, p. 661, doi. 10.2337/dc10-1925
    By:
    • BIRKELAND, KÅRE I.;
    • HOME, PHILIP D.;
    • WENDISCH, ULRICH;
    • RATNER, ROBERT E.;
    • JOHANSEN, THUE;
    • ENDAHL, LARS A.;
    • LYBY, KARSTEN;
    • JENDLE, JOHAN H.;
    • ROBERTS, ANTHONY P.;
    • DEVRIES, J. HANS;
    • MENEGHINI, LUIGI F.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50